£46.99

CRC Press Real-World Evidence in Drug Development and Evaluation (Chapman & Hall/CRC Biostatistics Series)

Price data last checked 22 day(s) ago - will refresh soon

View at Amazon

We'll watch every seller, every day. One email when your price arrives.

It has never been this cheap. We have no record of a lower price.

£47 today · cheaper than every other day in the last 3 months

NEW HERE?

Amazon shows you one price. We show you all of them.

Tosheroon watches Amazon prices so you don't have to. Every product on Amazon has a price history — we make it visible. Set the price you'd actually pay, and we'll email you the second it gets there. No app, no account, one email.

WHAT'S ON THIS PAGE

↓ Price chart
when this has been cheap or pricey
↓ Forecast
where the price is heading next
↓ Statistics
all-time high & low, recent range
↑ Price alert
name your number, we'll email you

Price History & Forecast

Grey patches = out of stock. Cheaper = lower on the chart. Hover for exact prices.

Last 69 days · 69 data points (no recent data)

Historical
Generating forecast…
£47.98 £46.89 £47.13 £47.37 £47.60 £47.84 £48.08 25 April 2026 12 May 2026 29 May 2026 15 June 2026 02 July 2026

Price Distribution

Price distribution over 69 days • 2 price levels

Days at Price
Current Price
61 days · current 8 days 0 15 31 46 61 £47 £48 Days at Price

Price Analysis

Most common price: £47 (61 days, 88.4%)

Price range: £47 - £48

Price levels: 2 different prices over 69 days

Description

Real-world evidence (RWE) has been at the forefront of pharmaceutical innovations. It plays an important role in transforming drug development from a process aimed at meeting regulatory expectations to an operating model that leverages data from disparate sources to aid business, regulatory, and healthcare decision making. Despite its many benefits, there is no single book systematically covering the latest development in the field. Written specifically for pharmaceutical practitioners, Real-World Evidence in Drug Development and Evaluation, presents a wide range of RWE applications throughout the lifecycle of drug product development. With contributions from experienced researchers in the pharmaceutical industry, the book discusses at length RWE opportunities, challenges, and solutions. Features Provides the first book and a single source of information on RWE in drug development Covers a broad array of topics on outcomes- and value-based RWE assessments Demonstrates proper Bayesian application and causal inference for real-world data (RWD) Presents real-world use cases to illustrate the use of advanced analytics and statistical methods to generate insights Offers a balanced discussion of practical RWE issues at hand and technical solutions suitable for practitioners with limited data science expertise

Product Specifications

Format
paperback
Domain
Amazon UK
Release Date
29 August 2022
Listed Since
03 June 2022

Barcode

No barcode data available

Similar Products You Might Like

Real-World Evidence in Drug Development and Evaluation (Chapman & Hall/CRC Biostatistics Series)
99% match

Real-World Evidence in Drug Development and Evaluation (Chapman & Hall/CRC Biostatistics Series)

CRC Press

£133.04 03 Jul 2026
Quantitative Evaluation of Safety in Drug Development: Design, Analysis and Reporting (Chapman & Hall/CRC Biostatistics Series)
97% match

Quantitative Evaluation of Safety in Drug Development: Design, Analysis and Reporting (Chapman & Hall/CRC Biostatistics Series)

CRC Press

£49.04 02 Jul 2026
Quantitative Evaluation of Safety in Drug Development: Design, Analysis and Reporting: 67 (Chapman & Hall/CRC Biostatistics Series)
97% match

Quantitative Evaluation of Safety in Drug Development: Design, Analysis and Reporting: 67 (Chapman & Hall/CRC Biostatistics Series)

CRC Press

£85.00 09 Jul 2026
Real-World Evidence in a Patient-Centric Digital Era (Chapman & Hall/CRC Biostatistics Series)
97% match

Real-World Evidence in a Patient-Centric Digital Era (Chapman & Hall/CRC Biostatistics Series)

Chapman and Hall/CRC

£43.99 06 Jul 2026
Real-World Evidence in a Patient-Centric Digital Era (Chapman & Hall/CRC Biostatistics Series)
97% match

Real-World Evidence in a Patient-Centric Digital Era (Chapman & Hall/CRC Biostatistics Series)

CRC Press

£97.00 09 Jul 2026
Theory of Drug Development (Chapman & Hall/CRC Biostatistics Series)
96% match

Theory of Drug Development (Chapman & Hall/CRC Biostatistics Series)

CRC Press

£61.46 08 Jul 2026
Theory of Drug Development: 61 (Chapman & Hall/CRC Biostatistics Series)
96% match

Theory of Drug Development: 61 (Chapman & Hall/CRC Biostatistics Series)

CRC Press

£80.00 14 Jul 2026
Springer - Real-World Evidence in Medical Product Development
96% match

Springer - Real-World Evidence in Medical Product Development

Springer

£102.00 06 Jul 2026
Exposure-Response Modeling: Methods and Practical Implementation (Chapman & Hall/CRC Biostatistics Series)
96% match

Exposure-Response Modeling: Methods and Practical Implementation (Chapman & Hall/CRC Biostatistics Series)

CRC Press

£50.99 02 Jul 2026
Causal Inference in Pharmaceutical Statistics (Chapman & Hall/CRC Biostatistics Series)
96% match

Causal Inference in Pharmaceutical Statistics (Chapman & Hall/CRC Biostatistics Series)

Chapman and Hall/CRC

£97.99 09 Jul 2026
Statistics In the Pharmaceutical Industry: 14 (Chapman & Hall/CRC Biostatistics Series)
96% match

Statistics In the Pharmaceutical Industry: 14 (Chapman & Hall/CRC Biostatistics Series)

CRC Press

£142.00 26 Jun 2026
Statistical Methods in Biomarker and Early Clinical Development
96% match

Statistical Methods in Biomarker and Early Clinical Development

Springer

£100.08 09 Jul 2026
Multiple Testing Problems in Pharmaceutical Statistics (Chapman & Hall/CRC Biostatistics Series)
96% match

Multiple Testing Problems in Pharmaceutical Statistics (Chapman & Hall/CRC Biostatistics Series)

Chapman and Hall/CRC

£48.50 08 Jul 2026
Medical Product Safety Evaluation: Biological Models and Statistical Methods (Chapman & Hall/CRC Biostatistics Series)
96% match

Medical Product Safety Evaluation: Biological Models and Statistical Methods (Chapman & Hall/CRC Biostatistics Series)

CRC Press

£66.46 06 Jul 2026
Bayesian Analysis with R for Drug Development: Concepts, Algorithms, and Case Studies (Chapman & Hall/CRC Biostatistics Series)
96% match

Bayesian Analysis with R for Drug Development: Concepts, Algorithms, and Case Studies (Chapman & Hall/CRC Biostatistics Series)

CRC Press

£44.75 04 Jul 2026
Bayesian Analysis with R for Drug Development: Concepts, Algorithms, and Case Studies (Chapman & Hall/CRC Biostatistics Series)
96% match

Bayesian Analysis with R for Drug Development: Concepts, Algorithms, and Case Studies (Chapman & Hall/CRC Biostatistics Series)

CRC Press

£95.24 03 Jul 2026
Benefit-Risk Assessment in Pharmaceutical Research and Development (Chapman & Hall/CRC Biostatistics Series)
96% match

Benefit-Risk Assessment in Pharmaceutical Research and Development (Chapman & Hall/CRC Biostatistics Series)

CRC Press

£75.00 04 Jul 2026
Quantitative Decisions in Drug Development (Springer Series in Pharmaceutical Statistics)
96% match

Quantitative Decisions in Drug Development (Springer Series in Pharmaceutical Statistics)

Springer

£45.86 01 Jul 2026
Quantitative Decisions in Drug Development (Springer Series in Pharmaceutical Statistics)
96% match

Quantitative Decisions in Drug Development (Springer Series in Pharmaceutical Statistics)

Springer

£65.57 30 Jun 2026
Pharmaceutical Statistics Using SAS: A Practical Guide (SAS Press)
95% match

Pharmaceutical Statistics Using SAS: A Practical Guide (SAS Press)

SAS Institute

£74.12 15 Jul 2026
Global New Drug Development: An Introduction (ULLA Series in Pharmaceutical Sciences)
95% match

Global New Drug Development: An Introduction (ULLA Series in Pharmaceutical Sciences)

Wiley

£57.12 11 Jul 2026
Wiley Handbook of Current and Emerging Drug Therapies, Volumes 5 - 8
95% match

Wiley Handbook of Current and Emerging Drug Therapies, Volumes 5 - 8

Wiley

£176.21 24 Jun 2026
Propelling Innovation in New Drugs: Recommendations & Considerations (Pharmacology-Research, Safety Testing and Regulation)
95% match

Propelling Innovation in New Drugs: Recommendations & Considerations (Pharmacology-Research, Safety Testing and Regulation)

£13.46 11 Jul 2026
Statistical Applications for Chemistry, Manufacturing and Controls (CMC) in the Pharmaceutical Industry (Statistics for Biology and Health)
95% match

Statistical Applications for Chemistry, Manufacturing and Controls (CMC) in the Pharmaceutical Industry (Statistics for Biology and Health)

Springer

£59.67 04 Jul 2026